Recent knowledge in favor of remdesivir (GS-5734) as a therapeutic option for the COVID-19 infections

• Main Authors: S. Saqrane (Author), M.A. El Mhammedi (Author), S. Lahrich (Author), F. Laghrib (Author), Y. El Bouabi (Author), A. Farahi (Author), M. Bakasse (Author)
• Format: Book
• Published: Elsevier, 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The management of SARS-CoV-2 has not yet been clearly determined and is based on potential therapies evaluated during the SARS-CoV and MERS-CoV outbreaks. An emerging potential therapeutic approach currently being evaluated in numerous clinical trials is the remdesivir agent, which acts on COVID-19...